IGF-1 LR3
IGF-1 LR3 is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials.
- Human evidencen/a
- Animal evidencen/a
- Mechanisticn/a
- Safety knowledgen/a
- Editorial confidence3/5
Evidence Snapshot
- Overall
- 2/5Emerging / preliminary
- Human
- 0/5None identified
- Animal
- 2/5Some animal evidence
- In-vitro
- 0/5None identified
- Safety
- 0/5None identified
Scientific identity
- Peptide family
- Investigational peptide or analogue
- Entity class
- Research peptide
- Alternative names
- Long R3 IGF-1LR3 IGF-1LongR3-IGF-I
IGF-1 LR3 entered research, clinical or commercial use through investigation of its proposed biological, cosmetic or therapeutic activity.
Proposed Mechanisms
- Growth hormone axis →low_to_review
- IGF-1 receptor signalling →supported
Reported / Studied Uses
- Muscle massEvidence · insufficient
- discussed_or_researched_forEvidence · low to review
- Hair Loss / Hair ImprovementEvidence · low
- Muscle growthEvidence · insufficient
Human Evidence
Human evidence is absent, limited, early phase or indication-specific.
Animal Evidence
Animal evidence may support biological activity but does not establish clinical efficacy.
Safety & Unknowns
Regulatory Status
| Country | Status | Notes |
|---|
Community Observations
References
- No verified references linked yet. Editors will add primary sources.
Full Disclaimer
This page is for educational information only. It does not constitute medical advice, diagnosis, treatment, dosing guidance, or a recommendation to use any peptide, medicine or research chemical. Many peptides discussed on Atlas are not approved for human use in most jurisdictions and may have limited or unknown long-term safety data.
Community observations shown on this page are anonymised, moderated and observational only. They do not establish safety or effectiveness.
Always consult a qualified healthcare professional before making decisions about your health. See medical disclaimer and methodology.